In the cellular Tauopathy models, heparin has the potential to activate differential signaling pathways within cells that are not related to Tau fibril treatment53–58, and stimulate the aberrant modifications of Tau monomers59 or fibrils in cells. The gene discussed is MAPT; the disease is tauopathy.